Rockville, MD and Ann Arbor, MI (PRWEB) February 18, 2014
Health Level Seven® (HL7®) International and AEGIS.net (AEGIS) today announced the launch of a new Conformance Testing Program for HL7 standards. The HL7 Conformance Testing Program provides a platform for ongoing, iterative testing that helps healthcare IT developers get highly interoperable products to market quickly and cost-effectively. The testing program will make interoperability more cost-effective for vendors as well as implementers by reducing interface development time and costs.
“We chose to partner with AEGIS because they’re an industry leader in the testing of interoperability between Health Information Technology systems and HIEs,” said Charles Jaffe, MD, PhD, CEO of HL7 International. “Going forward, HL7 anticipates using the AEGIS Developers Integration Lab to provide a testing platform for both existing and new HL7 standards.”
The Conformance Testing Program leverages the technology and architecture of the AEGIS Developers Integration Lab (DIL). The DIL is an Infrastructure as a Service (IaaS) and Testing as a Service (TaaS) open source testing solution for health information exchange gateway, interoperability, and compatibility testing. The DIL helps automate and execute test cases created by HL7, providing an easy-to-use system for ongoing, iterative, 24/7/365 conformance and interoperability tests against published HL7 specifications.
Mario Hyland, Senior Vice President of AEGIS said, "AEGIS is proud to partner with HL7 International to bring its members a unique benefit offering HL7-specific conformance testing for continuous interoperability through the AEGIS DIL."
The program is currently in a pilot phase, during which supported standards are limited to Version 2 Immunization Registries. Participation will be free of charge until the HL7 Working Group Meeting in September 2014.
HL7 and AEGIS are hosting an in-depth round table briefing with Q&A on the Conformance Testing Program for media and conference attendees at the HL7 Booth (#1265 in Hall A) at the HIMSS14 Conference in Orlando, FL on Tuesday, Feb. 25, 2014 from 12:20 p.m. to 1:30 p.m. Speakers will include HL7 and AEGIS leadership, as well as program participants.
Live presentations will take place at these times:
HL7 Conformance Testing Program
About HL7 International (HIMSS14 Booth #1265)
Founded in 1987, Health Level Seven International (HL7) is a not-for-profit, ANSI-accredited standards developing organization dedicated to providing a comprehensive framework and related standards for the exchange, integration, sharing, and retrieval of electronic health information that supports clinical practice and the management, delivery and evaluation of health services. HL7's 2,000+ members include approximately 500 corporate members who represent more than 90% of the information systems vendors serving healthcare. HL7 provides standards for interoperability that improve care delivery, optimize workflow, reduce ambiguity and enhance knowledge transfer among all of our stakeholders, including healthcare providers, government agencies, the vendor community, fellow SDOs and patients.
About AEGIS (HIMSS14 Booth #8545)
AEGIS.net, Inc. is a CMMI Maturity Level 3 rated, ISO 9001:2008 certified small business and premier provider of Information Technology consulting services to Federal Civilian, Defense and Commercial sector clients. Our services, delivered by practitioners averaging more than 15 years of experience, include Project Management, Software Functional and Performance Testing, Application Design/Development, and Independent Verification and Validation (IV&V) and Organizational Performance/Process Improvement. Our domains of expertise include health IT and interoperability, regulatory compliance, finance, human resources, and logistics. AEGIS is recognized as a global community leader in innovation of Health IT interoperability, testing, analytics, and informatics.
®Capability Maturity Model, Carnegie Mellon and CMMI are registered in the U.S. Patent and Trademark Office by Carnegie Mellon University.